260P Antitumor activity of trastuzumab deruxtecan (T-DXd) in patients with metastatic breast cancer (mBC) and brain metastases (BMs) from DAISY trial

Autor: Epaillard, N., Lusque, A., Pistilli, B., André, F., Bachelot, T., Pierga, J-Y., Ducoulombier, A., Jouannaud, C., Viret, F., Salabert, L., Johnson, A.C., Deluche, E., Durando, X., Petit, T., Filleron, T., Mahier Ait Oukhatar, C., Dieras, V.C., Mosele, M.F.
Zdroj: In Annals of Oncology September 2022 33 Supplement 7:S656-S656
Databáze: ScienceDirect